Quarterly Consolidated Statement Of Cash Flows

Pharmarise Holdings Corporation - Filing #7289113

Concept As at
2024-11-30
2024-06-01 to
2024-11-30
As at
2024-05-31
As at
2023-11-30
2023-06-01 to
2023-11-30
As at
2023-05-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
45,000,000 JPY
2,210,000,000 JPY
Interest and dividends received
7,000,000 JPY
1,000,000 JPY
Interest paid
-76,000,000 JPY
-28,000,000 JPY
Net cash provided by (used in) operating activities
-200,000,000 JPY
1,860,000,000 JPY
Cash flows from investing activities
Proceeds from sale of securities
19,000,000 JPY
JPY
Purchase of property, plant and equipment
-339,000,000 JPY
-317,000,000 JPY
Proceeds from sale of property, plant and equipment
3,000,000 JPY
JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-30,000,000 JPY
-67,000,000 JPY
Loan advances
-1,000,000 JPY
0 JPY
Proceeds from collection of loans receivable
0 JPY
0 JPY
Other, net
108,000,000 JPY
7,000,000 JPY
Net cash provided by (used in) investing activities
-537,000,000 JPY
-543,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
4,000,000,000 JPY
700,000,000 JPY
Repayments of long-term borrowings
-2,532,000,000 JPY
-1,296,000,000 JPY
Redemption of bonds
JPY
-228,000,000 JPY
Dividends paid
-224,000,000 JPY
-127,000,000 JPY
Purchase of shares of subsidiaries not resulting in change in scope of consolidation
JPY
-73,000,000 JPY
Net cash provided by (used in) financing activities
1,138,000,000 JPY
-1,128,000,000 JPY
Net increase (decrease) in cash and cash equivalents
400,000,000 JPY
188,000,000 JPY
Cash and cash equivalents
7,504,000,000 JPY
7,100,000,000 JPY
4,923,000,000 JPY
4,734,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.